| Product Code: ETC7750801 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Ustekinumab Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Ustekinumab Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Ustekinumab Market - Industry Life Cycle |
3.4 Japan Ustekinumab Market - Porter's Five Forces |
3.5 Japan Ustekinumab Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Ustekinumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Japan Ustekinumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis and other autoimmune diseases in Japan |
4.2.2 Growing adoption of biologics for the treatment of chronic conditions |
4.2.3 Favorable regulatory environment promoting innovation in the pharmaceutical sector |
4.3 Market Restraints |
4.3.1 High cost associated with ustekinumab treatment leading to affordability issues |
4.3.2 Competition from other biologic therapies in the market |
4.3.3 Potential side effects and safety concerns associated with ustekinumab use |
5 Japan Ustekinumab Market Trends |
6 Japan Ustekinumab Market, By Types |
6.1 Japan Ustekinumab Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Ustekinumab Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Ustekinumab Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.1.4 Japan Ustekinumab Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2 Japan Ustekinumab Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Ustekinumab Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.2.3 Japan Ustekinumab Market Revenues & Volume, By Colitis, 2021- 2031F |
6.2.4 Japan Ustekinumab Market Revenues & Volume, By Lupus Erythematosus, 2021- 2031F |
6.2.5 Japan Ustekinumab Market Revenues & Volume, By Myositis Multiplex With Palmoplantar Pustulosis, 2021- 2031F |
6.2.6 Japan Ustekinumab Market Revenues & Volume, By Cirrhosis Of The Liver, 2021- 2031F |
6.2.7 Japan Ustekinumab Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.2.8 Japan Ustekinumab Market Revenues & Volume, By Other, 2021- 2031F |
6.2.9 Japan Ustekinumab Market Revenues & Volume, By Other, 2021- 2031F |
7 Japan Ustekinumab Market Import-Export Trade Statistics |
7.1 Japan Ustekinumab Market Export to Major Countries |
7.2 Japan Ustekinumab Market Imports from Major Countries |
8 Japan Ustekinumab Market Key Performance Indicators |
8.1 Patient adherence rate to ustekinumab treatment |
8.2 Number of healthcare providers prescribing ustekinumab |
8.3 Rate of new clinical trials and research studies on ustekinumab |
8.4 Patient satisfaction and reported outcomes with ustekinumab therapy |
8.5 Market access and reimbursement policies for ustekinumab |
9 Japan Ustekinumab Market - Opportunity Assessment |
9.1 Japan Ustekinumab Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Ustekinumab Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Japan Ustekinumab Market - Competitive Landscape |
10.1 Japan Ustekinumab Market Revenue Share, By Companies, 2024 |
10.2 Japan Ustekinumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here